Aakaar Medical Technologies Ltd vs Chennai Meenakshi Multispeciality Hospital Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Aakaar Medical Technologies Ltd is ₹ 71.4 as of 16 Jun 15:30 . The P/E Ratio of Aakaar Medical Technologies Ltd changed from 10.3 on March 2026 to 10.3 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Chennai Meenakshi Multispeciality Hospital Ltd changed from 4.3 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 years The Market Cap of Aakaar Medical Technologies Ltd changed from ₹ 68.17 crore on March 2026 to ₹ 68.17 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 7.28 crore on March 2021 to ₹ 24.66 crore on March 2026 . This represents a CAGR of 22.55% over 6 years The revenue of Aakaar Medical Technologies Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 8.7 crore as compare to the Mar '26 revenue of ₹ 10.05 crore. This represent the decline of -13.43% The ebitda of Aakaar Medical Technologies Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0.46 crore as compare to the Mar '26 ebitda of ₹ 0.48 crore. This represent the decline of -4.17% The net profit of Aakaar Medical Technologies Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ -0.38 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Aakaar Medical Technologies Ltd changed from 34.57 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aakaar Medical Technologies Ltd

Aakaar Medical Technologies Limited was originally incorporated as Aakaar Medical Technologies Private Limited', a private limited company dated June 20, 2013 issued by the Registrar of Companies, Mumbai.
Subsequently, Company status was converted into a public limited company and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of Company to Aakaar Medical Technologies Limited'. Incorporated in 2013, Aakaar Medicals are a medical aesthetic company dealing in a wide range of aesthetics & specialised cosmetic products & devices.
The Company supply its products & devices primarily to aesthetic physicians such as dermatologists, plastic surgeons, aesthetic physicians who sell these products to end consumers as well as use certain device consumables as part of their treatments.

About Chennai Meenakshi Multispeciality Hospital Ltd

Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, was incorporated in 1990.
The Company name was changed from Devaki Hospital Limited to Chennai Meenakshi Multispeciality Hospital Limited in October, 2007.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore.
The hospital has an infrastructure comprising of around 105 Beds including ICU Beds, Operating Theatre, a modern dialysis Unit besides a host of other facilities.
The Company has a pool of talented and experienced doctors who are further supported by a team of highly qualified and experienced and dedicated support staff and cutting edge technology. The Company operate into various departments like Cardiology Department; Casualty Department; Diagnostic Services; Intensive Care Unit; Nephrology Department and Physiotherapy Department.

FAQs for the comparison of Aakaar Medical Technologies Ltd and Chennai Meenakshi Multispeciality Hospital Ltd

Which company has a larger market capitalization, Aakaar Medical Technologies Ltd or Chennai Meenakshi Multispeciality Hospital Ltd?

Market cap of Aakaar Medical Technologies Ltd is 100 Cr while Market cap of Chennai Meenakshi Multispeciality Hospital Ltd is 24 Cr

What are the key factors driving the stock performance of Aakaar Medical Technologies Ltd and Chennai Meenakshi Multispeciality Hospital Ltd?

The stock performance of Aakaar Medical Technologies Ltd and Chennai Meenakshi Multispeciality Hospital Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aakaar Medical Technologies Ltd and Chennai Meenakshi Multispeciality Hospital Ltd?

As of October 31, 2026, the Aakaar Medical Technologies Ltd stock price is INR ₹71.0. On the other hand, Chennai Meenakshi Multispeciality Hospital Ltd stock price is INR ₹33.15.

How do dividend payouts of Aakaar Medical Technologies Ltd and Chennai Meenakshi Multispeciality Hospital Ltd compare?

To compare the dividend payouts of Aakaar Medical Technologies Ltd and Chennai Meenakshi Multispeciality Hospital Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.